Literature DB >> 12552458

Priming of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cell responses by dendritic cells loaded with HIV-1 proteins.

Xiao-Li Huang1, Zheng Fan, Lian Zheng, Luann Borowski, Hongyi Li, Elaine K Thomas, William H Hildebrand, Xiao-Qing Zhao, Charles R Rinaldo.   

Abstract

Proteins may serve as ideal CD8(+) T cell immunogens for human immunodeficiency virus type 1 (HIV-1) if they can be delivered to and processed through the human leukocyte antigen class I pathway. This study shows that human blood monocyte-derived dendritic cells loaded with liposome-complexed HIV-1 proteins and matured with CD40 ligand can prime CD8(+) T cells to HIV-1 in vitro. Whole HIV-1 protein in liposome may be an effective immunogen for HIV-1 vaccine protocols.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12552458     DOI: 10.1086/346054

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus.

Authors:  Delphine Pannetier; Stéphanie Reynard; Marion Russier; Alexandra Journeaux; Noël Tordo; Vincent Deubel; Sylvain Baize
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

Review 2.  The specialized roles of immature and mature dendritic cells in antigen cross-presentation.

Authors:  Richard A Hopkins; John E Connolly
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

3.  Presentation of human T cell leukemia virus type 1 (HTLV-1) Tax protein by dendritic cells: the underlying mechanism of HTLV-1-associated neuroinflammatory disease.

Authors:  Sharrón L Manuel; Todd D Schell; Edward Acheampong; Saifur Rahman; Zafar K Khan; Pooja Jain
Journal:  J Leukoc Biol       Date:  2009-08-05       Impact factor: 4.962

4.  Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions.

Authors:  Tatiana M Garcia-Bates; Mariana L Palma; Chengli Shen; Andrea Gambotto; Bernard J C Macatangay; Robert L Ferris; Charles R Rinaldo; Robbie B Mailliard
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

5.  Primary human immunodeficiency virus type 1-specific CD8+ T-cell responses induced by myeloid dendritic cells.

Authors:  Bonnie A Colleton; Xiao-Li Huang; Nada M Melhem; Zheng Fan; Luann Borowski; Giovanna Rappocciolo; Charles R Rinaldo
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

6.  Processing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected persons.

Authors:  Xiao-Li Huang; Zheng Fan; Bonnie A Colleton; Rico Buchli; Hongyi Li; William H Hildebrand; Charles R Rinaldo
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

7.  Variable processing and cross-presentation of HIV by dendritic cells and macrophages shapes CTL immunodominance and immune escape.

Authors:  Jens Dinter; Ellen Duong; Nicole Y Lai; Matthew J Berberich; Georgio Kourjian; Edith Bracho-Sanchez; Duong Chu; Hang Su; Shao Chong Zhang; Sylvie Le Gall
Journal:  PLoS Pathog       Date:  2015-03-17       Impact factor: 6.823

8.  In vitro priming recapitulates in vivo HIV-1 specific T cell responses, revealing rapid loss of virus reactive CD4 T cells in acute HIV-1 infection.

Authors:  Rachel Lubong Sabado; Daniel G Kavanagh; Daniel E Kaufmann; Karlhans Fru; Ethan Babcock; Eric Rosenberg; Bruce Walker; Jeffrey Lifson; Nina Bhardwaj; Marie Larsson
Journal:  PLoS One       Date:  2009-01-23       Impact factor: 3.240

Review 9.  Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection.

Authors:  Chongbo Zhao; Zhujun Ao; Xiaojian Yao
Journal:  Vaccines (Basel)       Date:  2016-01-22

Review 10.  The Evolution of Dendritic Cell Immunotherapy against HIV-1 Infection: Improvements and Outlook.

Authors:  Hager Mohamed; Vandana Miller; Stephen R Jennings; Brian Wigdahl; Fred C Krebs
Journal:  J Immunol Res       Date:  2020-05-25       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.